PRINCETON - PDS Biotechnology Corporation (NASDAQ:PDSB) has confirmed plans to commence its VERSATILE-003 Phase 3 clinical trial for a promising cancer immunotherapy within the first quarter of 2025.

The IRS launched the pilot program known as Direct File in 2024 so that people can file their tax returns directly with the federal government.

Global Fashion Agenda (GFA) and PDS Ventures are searching for sustainable solutions that span the entire fashion supply ...